Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Bioanalytical Systems, Inc.    BASI

BIOANALYTICAL SYSTEMS, INC.

(BASI)
  Report
 SummaryQuotesChartsNewsCalendarCompanyFinancials 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
11/30/2020 12/01/2020 12/02/2020 12/03/2020 12/04/2020 Date
6.58(c) 6.75(c) 6.96(c) 7.06(c) 7.1(c) Last
26 137 45 572 67 761 44 947 38 072 Volume
+1.54% +2.58% +3.11% +1.44% +0.57% Change
More quotes
Financials (USD)
Sales 2018 26,3 M - -
Net income 2018 -0,19 M - -
Net Debt 2018 8,81 M - -
P/E ratio 2018 -72,8x
Yield 2018 -
Sales 2019 43,6 M - -
Net income 2019 -0,79 M - -
Net Debt 2019 16,0 M - -
P/E ratio 2019 -44,9x
Yield 2019 -
Capitalization 78,0 M 78,0 M -
EV / Sales 2018 0,96x
EV / Sales 2019 1,23x
Nbr of Employees 317
Free-Float 65,4%
More Financials
Company
Bioanalytical systems, Inc. is an international contract research company providing drug discovery and development services and analytical instruments. The Company operates in two segments: contract research services and research products. The contract research services segment provides research and development support on a contract basis to pharmaceutical companies. The research products segment provides liquid... 
More about the company
All news about BIOANALYTICAL SYSTEMS, INC.
10/20BIOANALYTICAL : Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice..
AQ
10/20Andrew N. Alexander, DVM, Ph.D., MBA, DABT, Joins Inotiv as Vice President, P..
GL
09/18BIOANALYTICAL SYSTEMS INC : Results of Operations and Financial Condition, Finan..
AQ
09/16BIOANALYTICAL SYSTEMS INC : Regulation FD Disclosure (form 8-K)
AQ
09/09BIOANALYTICAL : BASi to Participate in H.C. Wainright Investment Conference
AQ
09/09BASi to Participate in H.C. Wainright Investment Conference
GL
08/14BIOANALYTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
08/14BASi Releases Earnings for Third Quarter of Fiscal 2020
GL
08/11BIOANALYTICAL : I.M. (Gina) Grossi, Ph.D., Joins Inotiv as Vice President of Tox..
AQ
07/15MERCK : to Invest EUR18 Million in Swiss Laboratory
DJ
06/17BIOANALYTICAL SYSTEMS INC : Change in Directors or Principal Officers (form 8-K)
AQ
05/15BIOANALYTICAL SYSTEMS INC : Results of Operations and Financial Condition, Finan..
AQ
05/14BIOANALYTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND ..
AQ
05/14BASi Releases Earnings for Second Quarter of Fiscal 2020
GL
05/05Diane Tutko Francisco, Ph.D., Joins Inotiv to Lead Client Experience Team
GL
More news
News in other languages on BIOANALYTICAL SYSTEMS, INC.

- No features available -

More news
Chart BIOANALYTICAL SYSTEMS, INC.
Duration : Period :
Bioanalytical Systems, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOANALYTICAL SYSTEMS, INC.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Managers
NameTitle
Robert Leasure President, Chief Executive Officer & Director
Gregory C. Davis Chairman
Beth A. Taylor Chief Financial Officer & Vice President-Finance
Richard Allen Johnson Independent Director
Wendy Perrow Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
BIOANALYTICAL SYSTEMS, INC.43.43%78
MODERNA, INC.679.75%60 354
CELLTRION, INC.109.94%46 823
LONZA GROUP AG54.02%45 349
IQVIA HOLDINGS INC.10.42%32 710
SEAGEN INC.56.86%32 316